Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Helen Li M.D.

Helen Li, M.D.

 Helen Li, M.D.

Helen Li, M.D.

Full Member 
Cancer Research Program
The Methodist Hospital Research Institute

Methodist Eye Associates
The Methodist Hospital Physician Organization
Clinical Associate Professor of Ophthalmology
Weill Cornell Medical College

E-mail: hlimed@mac.com
Phone: 281-407-3033


M.D.   University of Texas Health Science Center, Houston, TX
B.S.   University of Pittsburgh, Pittsburgh, PA (Pharmacy)

Postdoctoral Training

Fellowship in Ocular Oncology, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA

Fellowship in Vitreoretinal, University of Tennessee, Knoxville, TN

Fellowship in Vitreoretinal, Houston Eye Associates, The University of Texas Health Science Center, Houston, TX 

Resident in Ophthalmology, The University of Texas Medical Branch, Galveston, TX

Intern, Baylor College of Medicine 



Dr. Helen Li specializes in ocular oncology and vitreoretinal diseases. She founded the Community Retina Group in Houston after almost twenty years of clinical practice at the University of Texas Medical Branch, where she received numerous teaching award from residents and fellows. Dr. Li served as director of the UTMB retina service and founded the retina fellowship program.  She regularly publishes her research in leading ophthalmology journals and presents on retinal diseases and ocular tumors at national and international scientific conferences.

Board certified by the American Board of Ophthalmology, Dr. Li is an active member of professional organizations, including the Macular Society, Retina Society, the International Society of Ocular Oncology, the American Uveitis Society, the Association of Research in Vision and the Ophthalmology and the American Telemedicine Association. 

Description of Research

Dr. Li has served as principle investigator of National Eye Institute, industry and foundation sponsored research and clinical trials.  Her research projects include the ocular complications of AIDS trial and the diabetic retinopathy clinical research network study.   She is currently interested in validating biomarkers for prognosis of melanoma in the eye and evaluating novel therapeutics for various types of ocular cancer.

Major Areas of Research

Ophthalmology, ocular oncology, teleophthalmology